BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34502173)

  • 1. Nanoarchitectonics: Complexes and Conjugates of Platinum Drugs with Silicon Containing Nanocarriers. An Overview.
    Piorecka K; Kurjata J; Stanczyk WA
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monofunctional and higher-valent platinum anticancer agents.
    Johnstone TC; Wilson JJ; Lippard SJ
    Inorg Chem; 2013 Nov; 52(21):12234-49. PubMed ID: 23738524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functionalized nonporous silica nanoparticles as carriers for Pt(iv) anticancer prodrugs.
    Ravera M; Gabano E; Zanellato I; Perin E; Arrais A; Osella D
    Dalton Trans; 2016 Nov; 45(43):17233-17240. PubMed ID: 27722707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance.
    Chen Q; Yang Y; Lin X; Ma W; Chen G; Li W; Wang X; Yu Z
    Chem Commun (Camb); 2018 May; 54(42):5369-5372. PubMed ID: 29744485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs.
    Ravera M; Perin E; Gabano E; Zanellato I; Panzarasa G; Sparnacci K; Laus M; Osella D
    J Inorg Biochem; 2015 Oct; 151():132-42. PubMed ID: 26277416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From The Mine to Cancer Therapy: Natural and Biodegradable Theranostic Silicon Nanocarriers from Diatoms for Sustained Delivery of Chemotherapeutics.
    Maher S; Kumeria T; Wang Y; Kaur G; Fathalla D; Fetih G; Santos A; Habib F; Evdokiou A; Losic D
    Adv Healthc Mater; 2016 Oct; 5(20):2667-2678. PubMed ID: 27594524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug.
    Ravera M; Gabano E; Bonzani D; Zanellato I; Arrais A; Cantamessa S; Biggiogera M; Osella D
    J Inorg Biochem; 2018 Dec; 189():185-191. PubMed ID: 30312905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in platinum chemotherapeutics.
    Harper BW; Krause-Heuer AM; Grant MP; Manohar M; Garbutcheon-Singh KB; Aldrich-Wright JR
    Chemistry; 2010 Jun; 16(24):7064-77. PubMed ID: 20533453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin B₁₂ as a carrier for targeted platinum delivery: in vitro cytotoxicity and mechanistic studies.
    Ruiz-Sánchez P; König C; Ferrari S; Alberto R
    J Biol Inorg Chem; 2011 Jan; 16(1):33-44. PubMed ID: 20803225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes.
    Zhong Y; Jia C; Zhang X; Liao X; Yang B; Cong Y; Pu S; Gao C
    Eur J Med Chem; 2020 May; 194():112229. PubMed ID: 32222677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts.
    Zhao Y; Woods JA; Farrer NJ; Robinson KS; Pracharova J; Kasparkova J; Novakova O; Li H; Salassa L; Pizarro AM; Clarkson GJ; Song L; Brabec V; Sadler PJ
    Chemistry; 2013 Jul; 19(29):9578-91. PubMed ID: 23733242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Approaches to Platinum(IV) Prodrugs: A Variety of Strategies for Enhanced Delivery and Efficacy.
    Najjar A; Rajabi N; Karaman R
    Curr Pharm Des; 2017; 23(16):2366-2376. PubMed ID: 28155621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarriers for delivery of platinum anticancer drugs.
    Oberoi HS; Nukolova NV; Kabanov AV; Bronich TK
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1667-85. PubMed ID: 24113520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin.
    Shi H; Cheng Q; Yuan S; Ding X; Liu Y
    Chemistry; 2015 Nov; 21(46):16547-54. PubMed ID: 26405808
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Lee VEY; Lim ZC; Chew SL; Ang WH
    Inorg Chem; 2021 Feb; 60(3):1823-1831. PubMed ID: 33464875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica microparticles enhance the cytotoxicity of anticancer platinum drugs.
    Tao Z; Toms B; Goodisman J; Asefa T
    ACS Nano; 2010 Feb; 4(2):789-94. PubMed ID: 20131868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Polyhedral Silsesquioxanes [POSS(OH)
    Piorecka K; Kurjata J; Stanczyk WA
    Molecules; 2020 Dec; 26(1):. PubMed ID: 33374161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
    Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
    Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coordination-driven self-assembly of a Pt(iv) prodrug-conjugated supramolecular hexagon.
    Yue Z; Wang H; Li Y; Qin Y; Xu L; Bowers DJ; Gangoda M; Li X; Yang HB; Zheng YR
    Chem Commun (Camb); 2018 Jan; 54(7):731-734. PubMed ID: 29303526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mono- and di-bromo platinum(IV) prodrugs via oxidative bromination: synthesis, characterization, and cytotoxicity.
    Xu Z; Wang Z; Yiu SM; Zhu G
    Dalton Trans; 2015 Dec; 44(46):19918-26. PubMed ID: 26514681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.